Atul Sharan

Atul Sharan co-founded CellMax Life in 2012, applying semiconductor industry principles to a proprietary Circulating Epithelial Cell Bio-Mimetic CMx platform to develop affordable and quantitative blood-tests for Early Cancer Detection and Treatment. He was motivated to start CellMax as two members of his family had been diagnosed with cancer – one of them was diagnosed with breast cancer within two weeks of receiving a conclusively negative mammogram. Atul is a veteran of the high-tech industry with experience as an engineer, serial entrepreneur, CEO and angel investor. Previously he was also resident at Mohr-Davidow Ventures and Artiman Ventures. He specializes in identifying unmet market needs and matching them with early-stage technologies to achieve dramatically better results than prevailing standards. He has done that successfully multiple times: AutoESL (acquired by Xilinx); ClearShape Technologies (acquired by Cadence), Numerical Technologies (Nasdaq IPO; acquired by Synopsys); Ambit Design (acquired by Cadence). Atul holds a BS in Engineering from IIT-India; MS in Engineering from UH, Texas and an MBA from UC-Berkeley.